Evicenter
Trodelvy (sacituzumab govitecan-hziy) in Metastatic triple-negative breast cancer
Manufacturer
Gilead Sciences, Inc.
Prescribing information
Trodelvy (opens in a new tab)
Questions
47
Last updated

All questions

Indication: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer

2 questions · 2 sources